Mufg Americas Holdings Corp Fibrogen Inc Transaction History

Mufg Americas Holdings Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$45.35 - $61.65 $7,392 - $10,048	-163 Reduced 23.76%	523 $24,000
Q4 2017 Feb 08, 2018	SELL	$41.95 - $60.1 $9,229 - $13,222	-220 Reduced 24.28%	686 $0
Q3 2017 Nov 13, 2017	SELL	$33.4 - $53.9 $1,469 - $2,371	-44 Reduced 4.63%	906 $0
Q2 2017 Aug 07, 2017	BUY	N/A	950	950 $0

37.4M

351K

105K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $34.7M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.